NCT06270550 Role of Dynamic Movement Intervention in Children with Spastic Diplegia
| NCT ID | NCT06270550 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Spastic Diplegia |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2025-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-03-01 with a primary completion date of 2025-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to investigate the effect of dynamic movement intervention approach on static and dynamic balance, quality of step length and cadence of walking pattern of children with spastic diplegic cerebral palsy.
Eligibility Criteria
Inclusion criteria: * Age ranged from 4-7 years. * They can walk alone short distance and climb stairs holding on rail (Grade I \& II according to GMFCS). * They can understand and execute instructions. * They will be medically stable. * Degree of spasticity will be ranged from 1 to 1+ degree according to the Modified Ashworth Scale. Exclusion criteria: * Visual impairment (visual loss- cataract- myopia- hyperopia). * Hearing impairment (deafness) * Cognitive problem. * Uncontrolled Convulsions. * Orthopedic surgery for the affected lower limbs within one year. * Botulinum toxin injection within the last 6 months or within the study period.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06270550 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 7 Years, studying Spastic Diplegia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06270550 currently recruiting?
Yes, NCT06270550 is actively recruiting participants. Contact the research team at crawara07@gmail.com for enrollment information.
Where is the NCT06270550 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06270550 clinical trial?
NCT06270550 is sponsored by Cairo University. The trial plans to enroll 40 participants.